Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Healthcare Biotechnology
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

ROSEN, A LEADING LAW FIRM, Encourages Twist Bioscience Corporation Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TWST

PR Newswire December 16, 2022

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)

Business Wire December 16, 2022

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile December 16, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2023 in Twist Lawsuit - TWST

Newsfile December 16, 2022

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Business Wire December 16, 2022

TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023

PR Newswire December 16, 2022

TWST INVESTORS: February 10, 2023 Filing Deadline in Securities Class Action - Contact Lieff Cabraser

Business Wire December 15, 2022

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Business Wire December 15, 2022

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed

Newsfile December 14, 2022

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Twist Bioscience Corporation (TWST)

Business Wire December 14, 2022

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Accesswire December 14, 2022

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Twist Bioscience Corporation (TWST) Investors

Business Wire December 14, 2022

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Twist Bioscience Corporation (TWST) Investors

Business Wire December 14, 2022

TWIST ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Twist Bioscience Corp and Encourages Investors to Contact the Firm

Business Wire December 13, 2022

Twist Deadline Alert

Newsfile December 13, 2022

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Twist Bioscience Corporation (TWST) Investors

Business Wire December 13, 2022

EQUITY NOTICE: Rosen Law Firm Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST

Business Wire December 13, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST

PR Newswire December 13, 2022

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Inquire About Securities Class Action Investigation - TWST

PR Newswire December 12, 2022

Kessler Topaz Meltzer & Check, LLP Announces the Firm Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation

Business Wire December 12, 2022